An Investigator-initiated Clinical Study of LM303 Injection for the Treatment of Advanced Solid Tumours

Summary

This is a single-arm, open-label, exploratory study to evaluate safety and efficacy of LM303 Injection in patients with advanced solid tumors. The purpose of this study is to evaluate the safety and tolerability, antitumor activity and immunoreactivity.

Timeline

Start

2024-10-17

Primary completion

2026-10

Completion

2027-10

Drugs

Indications